Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...

In an era where the biopharmaceutical landscape is rapidly evolving, a comprehensive approach to demonstrating and ...

At this year’s European Society for Medical Oncology (ESMO) Annual Meeting, pharmaphorum web editor Nicole Raleigh spoke with ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

The Galleri multi-cancer early detection (MCED) test – which looks for around 50 different types – achieved a seven-fold ...

As pharmaphorum reported during ESMO 2025, fresh from a return to oncology with the FDA approval of zongertinib as a ...

Millions of women worldwide live with endometriosis, which causes symptoms like pain and extreme tiredness and, if untreated, ...

On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

The results – presented at the ESMO cancer congress and simultaneously published in Annals of Oncology – come after seven ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...